TruTrace Technologies Inc Share Price Canadian Securities Exchange
Equities
CA8984471075
Advanced Medical Equipment & Technology
Sales 2021 | 0.16 0.22 13.55 | Sales 2022 | 0.12 0.16 9.88 | Capitalization | 3.82M 5.19M 318M |
---|---|---|---|---|---|
Net income 2021 | -1M -1.36M -83.39M | Net income 2022 | -2M -2.72M -167M | EV / Sales 2021 | 8,37,73,009 x |
Net cash position 2021 | 893K 1.21M 74.45M | Net Debt 2022 | 681K 927K 56.79M | EV / Sales 2022 | 3,79,73,468 x |
P/E ratio 2021 |
-6.71
x | P/E ratio 2022 |
-1.64
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 87.1% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 11/11/11 | |
Robert Lelovic
DFI | Director of Finance/CFO | - | 16/21/16 |
James LaValle
CTO | Chief Tech/Sci/R&D Officer | - | 21/19/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Cesare Fazari
BRD | Director/Board Member | - | 09/20/09 |
Robert Galarza
BRD | Director/Board Member | 45 | 17/18/17 |
Allan O'Dette
CHM | Chairman | - | 06/20/06 |
1st Jan change | Capi. | |
---|---|---|
+9.80% | 32.94B | |
+21.53% | 7.83B | |
+36.69% | 4.26B | |
-28.70% | 2.74B | |
-20.62% | 1.39B | |
-28.50% | 1.27B | |
-32.48% | 1.17B | |
+12.29% | 988M | |
-37.86% | 884M |